169 related articles for article (PubMed ID: 7606435)
1. Quantitative autoradiographic characterisation of the binding of [3H]WAY-100635, a selective 5-HT1A receptor antagonist.
Khawaja X
Brain Res; 1995 Mar; 673(2):217-25. PubMed ID: 7606435
[TBL] [Abstract][Full Text] [Related]
2. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brain.
Khawaja X; Evans N; Reilly Y; Ennis C; Minchin MC
J Neurochem; 1995 Jun; 64(6):2716-26. PubMed ID: 7760052
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.
Fletcher A; Forster EA; Bill DJ; Brown G; Cliffe IA; Hartley JE; Jones DE; McLenachan A; Stanhope KJ; Critchley DJ; Childs KJ; Middlefell VC; Lanfumey L; Corradetti R; Laporte AM; Gozlan H; Hamon M; Dourish CT
Behav Brain Res; 1996; 73(1-2):337-53. PubMed ID: 8788530
[TBL] [Abstract][Full Text] [Related]
5. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
6. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
Forster EA; Cliffe IA; Bill DJ; Dover GM; Jones D; Reilly Y; Fletcher A
Eur J Pharmacol; 1995 Jul; 281(1):81-8. PubMed ID: 8566121
[TBL] [Abstract][Full Text] [Related]
7. Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse.
Laporte AM; Lima L; Gozlan H; Hamon M
Eur J Pharmacol; 1994 Dec; 271(2-3):505-14. PubMed ID: 7705451
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
9. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.
Burnet PW; Eastwood SL; Harrison PJ
Neurochem Int; 1997 Jun; 30(6):565-74. PubMed ID: 9152998
[TBL] [Abstract][Full Text] [Related]
10. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain.
Hume SP; Ashworth S; Opacka-Juffry J; Ahier RG; Lammertsma AA; Pike VW; Cliffe IA; Fletcher A; White AC
Eur J Pharmacol; 1994 Dec; 271(2-3):515-23. PubMed ID: 7705452
[TBL] [Abstract][Full Text] [Related]
12. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635.
Hall H; Lundkvist C; Halldin C; Farde L; Pike VW; McCarron JA; Fletcher A; Cliffe IA; Barf T; Wikström H; Sedvall G
Brain Res; 1997 Jan; 745(1-2):96-108. PubMed ID: 9037397
[TBL] [Abstract][Full Text] [Related]
14. Differential regional antagonism of 8-OH-DPAT-induced decrease in serotonin synthesis by two 5-HT1A receptor antagonists.
Larsson LG; Stenfors C; Ross SB
Eur J Pharmacol; 1998 Apr; 346(2-3):209-15. PubMed ID: 9652362
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic localization and pharmacological characterization of [3H]tandospirone binding sites in the rat brain.
Tanaka H; Shimizu H; Kumasaka Y; Hirose A; Tatsuno T; Nakamura M
Brain Res; 1991 Apr; 546(2):181-9. PubMed ID: 1648988
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
Corradetti R; Le Poul E; Laaris N; Hamon M; Lanfumey L
J Pharmacol Exp Ther; 1996 Aug; 278(2):679-88. PubMed ID: 8768719
[TBL] [Abstract][Full Text] [Related]
17. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
[TBL] [Abstract][Full Text] [Related]
18. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
19. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
Jordan S; Chen R; Koprivica V; Hamilton R; Whitehead RE; Tottori K; Kikuchi T
Eur J Pharmacol; 2005 Jul; 517(3):165-73. PubMed ID: 15985260
[TBL] [Abstract][Full Text] [Related]
20. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist.
Jerning E; Svantesson GT; Mohell N
Eur J Pharmacol; 1998 Nov; 360(2-3):219-25. PubMed ID: 9851589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
